EP Patent

EP4471140A1 — Targeting ligand containing n-acetylgalactosamine

Assigned to Rona Bioscience Ltd · Expires 2024-12-04 · 1y expired

What this patent protects

Provided in the present invention is a ligand containing N-acetylgalactosamine, wherein the ligand contains a conjugated group as represented by formula (X') and a nucleic acid molecule containing the targeting ligand.

USPTO Abstract

Provided in the present invention is a ligand containing N-acetylgalactosamine, wherein the ligand contains a conjugated group as represented by formula (X') and a nucleic acid molecule containing the targeting ligand.

Drugs covered by this patent

Patent Metadata

Patent number
EP4471140A1
Jurisdiction
EP
Classification
—
Expires
2024-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Rona Bioscience Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.